0.000149936277082104 -7.49681385412649E-05 -0.00149936277082253 0.000224904415623369 0.00284878926456253 0.00404827948122042 0.00344853437289137 0.00547267411350168
Sign Up Today X
Thanks for submitting the form.
Stockreport

Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead Sciences and Amgen; SPDR S&P Biotech ETF (XBI) uses equal-weight methodology with 155 holdings across smaller companies and returned 77% over the same period, offering higher volatility and asymmetric upside; Direxion Daily S&P Biotech Bull 3X Shares (LABU) amplifies daily returns and gained 338% in the past year but loses 72% over a decade due to volatility decay and is designed for short-term trading only. Biotech ETFs offer three distinct risk-return profiles as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity drive capital back into the sector. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity pulled capital back into a sector that spent much of the prior cycle in drawdown. The three ETFs below offer distinct ways to participate: one anchors a p [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead Sciences and Amgen; SPDR S&P Biotech ETF (XBI) uses equal-weight methodology with 155 holdings across smaller companies and returned 77% over the same period, offering higher volatility and asymmetric upside; Direxion Daily S&P Biotech Bull 3X Shares (LABU) amplifies daily returns and gained 338% in the past year but loses 72% over a decade due to volatility decay and is designed for short-term trading only. Biotech ETFs offer three distinct risk-return profiles as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity drive capital back into the sector. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity pulled capital back into a sector that spent much of the prior cycle in drawdown. The three ETFs below offer distinct ways to participate: one anchors a p [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS